October 5, 2020 by Chain Drug Review
ACA, Affordable Care Act, Supreme Court
News, October 5, 2020

NEW YORK — Ever since it was signed into the law by President Obama on March 23, 2010, the Affordable Care Act has been under constant attack by Republicans seeking to undermine the former president’s signature legislation. Despite surviving numerous attempts by congressional Republicans to repeal it and its constitutionality being upheld by a majority-conservative
April 23, 2018 by Chain Drug Review
ACA, Centers for Medicaid and Medicare Services, CMS
Issue 04-23-2018, News
WASHINGTON — The Trump administration has shifted more control over the Affordable Care Act marketplaces to the states and given consumers more leeway to avoid participation this year. A new final rule issued recently by the Centers for Medicare and Medicaid Services (CMS) relaxes certain regulations regarding ACA health plans in order to drive competition
December 5, 2017 by Geoff Walden and Chain Drug Review
ACA, Affordable Care Act, individual mandate, John Barrasso, Mitch McConnell, Senate tax reform bill, Susan Collins
Issue 12-11-2017, News, Pharmacy, Retail News

WASHINGTON — The Senate’s repeal of the Affordable Care Act (ACA) individual mandate as part of its sweeping tax reform bill has likely spelled doom for the provision, which required people who didn’t obtain health insurance to pay a tax penalty. Sen. John Barrasso (R., Wyo.) said the 51-49 vote passing the Senate tax reform
July 28, 2017 by Bill Schiffner
ACA, Affordable Care Act, Chuck Schumer, John McCain, Lisa Murkowski, Mitch McConnell, skinny repeal, Susan Collins
Featured Articles, Leading Headlines, Pharmacy, Retail News

WASHINGTON — The Senate dealt a devastating blow to Republican efforts to repeal and replace the Affordable Care Act by defeating a GOP “skinny repeal” bill early Friday morning. Sens. John McCain (R., Ariz.), Lisa Murkowski (R., Alaska) and Susan Collins (R., Maine) joined with Democrats to oppose the measure, a major loss for President
May 15, 2017 by Jeffrey Woldt and Chain Drug Review
ACA, Affordable Care Act, AHCA, Alex Gourlay, American Health Care Act, Jeffrey Woldt, Martin Otto, NACDS, NACDS Annual Meeting, Steve Anderson, U.S. health care system
2017, Issue 05-15-2017, Issues, Opinion

After many fits and starts, Republicans in the House of Representatives have finally succeeded in passing a bill that would, if the Senate concurs, repeal the Affordable Care Act, the landmark legislation that provides the current framework for the U.S. health care system. Voting mostly along party lines — with 217 Republicans in favor and
May 11, 2017 by Chain Drug Review
ACA, ACHA, Affordable Care Act, American Health Care Act, B. Douglas Hoey, H.R. 1628, Mitch McConnell, National Community Pharmacists Association, NCPA
Leading Headlines, Pharmacy, Retail News

ALEXANDRIA, Va. — As the Senate gauges the House of Representatives’ bill to repeal the Affordable Care Act (ACA), the National Community Pharmacists Association has called for the retention of key pharmacy-related elements. NCPA on Thursday said it sent a letter to the Senate Majority Leader Mitch McConnell (R., Ky.) and a 12-member working group of
May 8, 2017 by Jeffrey Woldt and Chain Drug Review
ACA, Affordable Care Act, AHCA, Alex Gourlay, American Health Care Act, Future Value Targeting, Martin Otto, NACDS, NACDS Annual Meeting, Steve Anderson
Featured Articles, Leading Headlines, Opinion, Pharmacy

After many fits and starts, Republicans in the House of Representatives have finally succeeded in passing a bill that would, if the Senate concurs, repeal the Affordable Care Act, the landmark legislation that provides the current framework for the U.S. health care system. Voting mostly along party lines — with 217 Republicans in favor and
March 13, 2017 by Geoff Walden and Chain Drug Review
ACA, Affordable Care Act, Chuck Schumer, health care policy, health insurance, John Boehner, Obamacare, Paul Ryan, President Donald Trump
2017, Issue 03-13-2017, Issues, News
WASHINGTON — President Donald Trump has called for bipartisan support for an overhaul of the Affordable Care Act, but his own party was divided on the issue. In his first speech to a joint session of Congress, Trump asked Republicans and Democrats “to save Americans from this imploding Obamacare disaster.” Reiterating his campaign rhetoric, the
February 27, 2017 by Greg Jacobson and Chain Drug Review
ACA, ACA exchanges, Aetna, Affordable Care Act, Health and Human Services, health insurance exchanges, Humana, Mark Bertolini, Obamacare, Tom Price, Trump administration
2017, Issue 02-27-2017, Issues, News

WASHINGTON — Humana Inc.’s decision to pull out of the health insurance exchanges created by the Affordable Care Act threatens to cripple Obamacare before Republican lawmakers bent on its repeal can cobble together a replacement. The Humana decision came one day before the Trump administration issued a proposed rule that attempts to offer insurers more
February 21, 2017 by Greg Jacobson and Chain Drug Review
ACA, Aetna, Affordable Care Act, health insurance exchanges, Humana, Mark Bertolini, Obamacare, Tom Price
Featured Articles, Leading Headlines, Pharmacy, Retail News

WASHINGTON — Humana Inc.’s decision to pull out of the health insurance exchanges created by the Affordable Care Act threatens to cripple Obamacare before Republican lawmakers bent on its repeal can cobble together a replacement. The Humana decision came one day before the Trump White House issued a proposed rule that attempts to offer insurers
January 17, 2017 by Steve Anderson and Chain Drug Review
ACA, Affordable Care Act, Donald Trump, Medicaid pharmacy reimbursement, NACDS, NACDS RxIMPACT, National Association of Chain Drug Stores, Pharmacy and Medically Underserved Areas Enhancement Act, Seema Verma, Steve Anderson, Tom Price
Opinion

I will spare you the introductory paragraph that attempts eloquence. Let’s get right to the point. In NACDS’ view, 2017 could be one of the most pivotal years in health care policy and in pharmacy patient care. NACDS not only is ready to advocate for pharmacy in this unprecedented environment; that vital work already is
January 16, 2017 by Greg Jacobson and Chain Drug Review
ACA, Affordable Care Act, Chris Collins, Donald Trump, Mike Pence, Obamacare
2017, Issue 01-16-2017, Issues, News

WASHINGTON — Republicans in the Senate and House of Representatives are aggressively pushing ahead with measures to repeal the Affordable Care Act despite the fact that they have no coherent alternative to replace it. Health care industry analysts and trade associations have warned that repealing or gutting the law without an adequate substitute could create
January 16, 2017 by Jeffrey Woldt and Chain Drug Review
ACA, Affordable Care Act, Barack Obama, Donald Trump, Jeffrey Woldt, Mike Pence, Obamacare, retail pharmacies
2017, Issue 01-16-2017, Issues, Leading Headlines, Opinion

After stumbling out of the gate early this month with an ill-conceived bid to hamstring the Office of Congressional Ethics (a plan that roused a chorus of critics, including President-elect Donald Trump, and was quickly withdrawn), Republicans in the House, along with their colleagues in the Senate, regained their footing and set about the business
December 12, 2016 by Geoff Walden and Chain Drug Review
ACA, Affordable Care Act, Centers for Medicare & Medicaid Services, CMS, Department of Health and Human Services, Donald Trump, HHS, National Association of Chain Drug Stores, Obamacare, Seema Verma, Steve Anderson, Tom Price
2016, Issue 12-12-2016, Issues, Leading Headlines, News, Pharmacy, Retail News

WASHINGTON — The choices of Tom Price and Seema Verma for top health positions under Donald Trump have reaffirmed the president-elect’s commitment to toppling the Affordable Care Act. Price, a six-term Republican congressman from Georgia and fierce critic of Obamacare, was picked as secretary of the Department of Health and Human Services (HHS), while Verma,